What's New New Analyst Reports Information What's New 09/19/2024NEWASANTE(6073)Notice Concerning the Results of the Tender Offer, the Completion of the Acquisition of Treasury Shares, and the Changes of the Major Shareholders09/18/2024NEWYAMAZEN(8051)Notice Regrading Change in Specified SubsidiaryAnGes(4563)Collategene (HGF gene therapy product) was granted Breakthrough Therapy designation by FDAELECOM(6750)Sustainability Report 2024¡ÊENG¡Ë09/17/2024First-corporation(1430)[ IR STREET REPORT ]: Sales target for the final year of Innovation2024 is 40 billion yen. With an annual sales goal of 100 billion yen, the Company is on track with a clear path ahead!MELCO HOLDINGS(6676)[Delayed](Revised edition) Q&A-format Explanation Regarding Dividends in Kind of Subsidiary and Change of Specified Subsidiaries[Delayed]Q&A-format Explanation Regarding Dividends in Kind of Subsidiary Shares(Share-Distribution-Type Spin-off)and Change of Specified SubsidiariesFerrotec Holdings(6890)Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q1 FY03/25 [Report Update]09/13/2024MELCO HOLDINGS(6676)Analyst Report(Shared Research) : Cancellation of treasury sharesCrossfor(7810)Consolidated Financial Results for the Fiscal Year Ended July 31, 2024 (Under Japanese GAAP)Saint Marc Holdings(3395)Monthly Sales Report August 2024SBS Holdings(2384)Notice of Personnel Changes09/12/2024Royal Holdings(8179)August 2024 Monthly Sales Report (Same-store sales)TOP CULTURE(7640)Consolidated Financial Results for the Nine Months Ended July 31, 2024 (Under Japanese GAAP)SWCC(5805)Q&A Sessions at the Small Meeting (1Q FY3/2025)09/11/2024HOTLAND(3196)Monthly Sales Report (August)inspec(6656)Non-consolidated Financial Results for the Three Months Ended July 31, 2024 (Under Japanese GAAP)Global Information(4171)Financial Results for Q2 FY12/2409/10/2024The Monogatari Corporation(3097)Notice Regarding August 2024 Preliminary Monthly YoY Change in Sales and Number of RestaurantsHUB(3030)August 2024 Monthly ReportVerite(9904)August 2024 Flash Report vs. LY09/09/2024Digital Information Technologies(3916)[Delayed]New Medium-term Management Plan[Delayed]Financial Results for the Fiscal Year Ended June 2024ASANTE(6073)August Monthly Sales Report for FY Ending March 2025WATTS(2735)Notice Regarding August 2024 Monthly YoY Change in Sales and Number of Shops09/06/2024SBS Holdings(2384)Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q2 FY12/24 [Report Update]create restaurants holdings(3387)Notice of Acquisition of Shares of Ichigen Food Company Co., Ltd.09/05/2024Mcdonald's Holdings(Japan)(2702)Monthly IR NewsCUBE(7112)[Delayed] [FY12/24] Preliminary Monthly Sales Report of Directly Managed Stores for August 2024SANYEI CORPORATION(8119)Notice of Stock Split, and Amendments to Articles of Incorporation and Revision of Dividend Forecast accompanying the Stok SplitDigital Information Technologies(3916)Notice of Convocation Annual General Meeting 202409/04/2024NS TOOL(6157)Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q1 FY03/25 [Report Update]The Monogatari Corporation(3097)Notice of the 55th Annual General Meeting of ShareholdersFerrotec Holdings(6890)Notice of the Selection of Our Stock as a JPX-Nikkei Index 400 and a JPX-Nikkei Mid and Small Cap Index ConstituentsGREENS(6547)Notice of Convocation of the 61st Ordinary General Meeting of Shareholders&Do Holdings(3457)Notice of the 16th Ordinary General Meeting of Shareholders09/03/2024TOP CULTURE(7640)FY10/2024 Preliminary sales figures (August)&Do Holdings(3457)Announcement Regarding Payment of DividendsShared Research Inc. short report on earnings results for the FY06/2024 has been issuedCUBE(7112)[Delayed]Financial results briefing materials for the Second Quarter of the Fiscal Year Ending December 31, 2024SBS Holdings(2384)Q2 of FY12/24 Financial Results Briefing Carna Biosciences(4572)Analyst Report(Shared Research): Decision to initiate the dose-expansion phase in the Phase 1b trial of the BTK inhibitor AS-1763Open Up Group(2154)Notice of the 20th Ordinary General Shareholders' Meeting09/02/2024Carna Biosciences(4572)Carna Opens Dose Expansion Part of Phase 1b Study for Next Generation BTK Inhibitor AS-1763MELCO HOLDINGS(6676)Notice Concerning Status of Purchase of Treasury Shares08/30/2024Fast Fitness Japan(7092)Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q1 FY03/25 [Report Update] Dream Incubator(4310)Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q1 FY03/25 [Report Update] SEGA SAMMY HOLDINGS(6460)Notice of Completion for Disposal of Treasury Stock by Third-Party AllotmentNotice of Granting of Post-delivery Restricted Stock Unit (RSU) and Performance Share Unit (PSU)Sansei Landic(3277)[Delayed]Medium-Term Management Plan (August2024-FY2027)[Delayed]Supplementary Materials for Consolidated Financial Results for 2Q of FY12/2408/29/2024Infomart(2492)Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q2 FY12/24 [Report Update]08/28/2024Carna Biosciences(4572)Analyst Report(Shared Research): Patent allowance in Europe for a joint patent application filed with Gilead SciencesMELCO HOLDINGS(6676)Analyst Report(Shared Research) : Tokyo Stock Exchange approves Shimadaya listing; Melco revises full-year earnings and dividend forecastsEPCO(2311)Analyst Report(Shared Research) : Monthly results for July 2024MELCO HOLDINGS(6676)[Delayed]Notice Concerning Proportion of Distributed Assets (Estimate of Proportion to be Finalized) Related to Dividends in Kind of Subsidiary SharesRoyal Holdings(8179)Financial Results for the Six Months Ended June 30, 202408/27/2024NICHIREKI(5011)Conclusion of Absorption-Type Company Split Agreement in connection with Transition to Holding Company Structure through Company SplitHYOJITO(7368)Non-consolidated Financial Results for the Three Months Ended June 30, 2024 (Under Japanese GAAP)08/26/2024CTI Engineering(9621)[delayed] Q & A on the 2Q62nd (2024) Financial Results Presentation08/23/2024Open Up Group(2154)Notice of Monthly Disclosure of Utilization Rates and Number of Domestic Engineers as of the end of July 2024AnGes(4563)Notice Concerning Termination of Exclusive Sales Rights Agreements for HGF Gene Therapy Product "Collategene"08/22/2024Dream Incubator(4310)Q1 FY03/2025 Supplementary Materials for Consolidated Financial ResultsDigital Information Technologies(3916)[Delayed]Notice of Decision on Matters Related to Acquisition of Treasury SharesEPCO(2311)[Delayed]FY2024 Q2 Financial Results (January-June)Open Up Group(2154)FY24 Q4 Financial Results and New Mid-Term Management Policy08/21/2024TSUBURAYA FIELDS HOLDINGS(2767)Financial Presentation for the first quarter of fiscal year ending March 31, 2025ELECOM(6750)Finalization of Details of the Issue of Stock Options (Stock Acquisition Rights)The Monogatari Corporation(3097)Fiscal Year Ended June 30, 2024 Financial ResultsSWCC(5805)Supplementary Material for the First Quarter of the Fiscal Year Ending March 2025 New Analyst Reports 9/17 Ferrotec Holdings Corporation(6890) Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q1 FY03/25 [Report Update] 9/12 MELCO HOLDINGS INC.(6676) Analyst Report(Shared Research) : Cancellation of treasury shares 9/11 SWCC Corporation(5805) Q&A Sessions at the Small Meeting (1Q FY3/2025) 9/5 SBS Holdings,Inc(2384) Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q2 FY12/24 [Report Update] 9/4 First-corporation Inc.(1430) [ IR STREET REPORT ]: Sales target for the final year of Innovation2024 is 40 billion yen. With an annual sales goal of 100 billion yen, the Company is on track with a clear path ahead! 9/3 Carna Biosciences, Inc.(4572) Analyst Report(Shared Research): Decision to initiate the dose-expansion phase in the Phase 1b trial of the BTK inhibitor AS-1763 8/30 Dream Incubator Inc.(4310) Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q1 FY03/25 [Report Update] 8/29 Infomart Corporation(2492) Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q2 FY12/24 [Report Update] 8/28 NS TOOL CO.,LTD.(6157) Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q1 FY03/25 [Report Update] 8/28 Fast Fitness Japan Incorporated(7092) Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q1 FY03/25 [Report Update] 8/26 EPCO Co.,Ltd.(2311) Analyst Report(Shared Research) : Monthly results for July 2024 8/16 &Do Holdings Co.,Ltd.(3457) Shared Research Inc. short report on earnings results for the FY06/2024 has been issued 8/9 Hakudo Co.,Ltd.(7637) Analyst Report(Shared Research) : Revisions to 1H earnings and dividend forecasts 8/9 TSUBURAYA FIELDS HOLDINGS INC.(2767) Analyst Report(Shared Research) : Released Q1 FY03/25 results Information Information 9/2 What's new: HYOJITO (7368) 7/22 What's new: VT HOLDINGS (7593) Newly Added Company Date¡§9/2 HYOJITO¡Ê7368¡§Standard¡Ë Date¡§7/22 VT HOLDINGS¡Ê7593¡§Prime¡Ë Latest Video & Presentations Latest Video&Slides Company newsprovided by Timely Disclosure Network News Release Stock Code or Name: 6417 SANKYO CO.,LTD. 09/19/2024 15:00 Notice of Announcement of the Earnings Forecast for the first Six Months of the Fiscal Year Ending March 31, 2025 and Dividend Forecast 08/07/2024 15:00 Presentation on Business Results for the First Quarter of FY 3/2025 08/07/2024 15:00 Consolidated Financial Statements for the First Quarter of FY2025 06/28/2024 10:30 Corporate Governance Report 06/15/2024 08:00 Supplementary Explanation Regarding Item to Be Proposed at the 59th Ordinary General Meeting of Shareholders 06/03/2024 08:00 NOTICE OF THE 59th ORDINARY GENERAL MEETING OF SHAREHOLDERS 05/24/2024 15:00 Notice concerning Partial Amendments to the Articles of Incorporation 05/24/2024 15:00 Notice Concerning Dividends of Surplus 05/09/2024 15:00 Notice Concerning the Formulation of the Mid-term Management Plan 05/09/2024 15:00 Presentation on Business Results of FY 3/2024 05/09/2024 15:00 Consolidated Financial Statements Results for the fiscal year ended March 31, 2024 04/16/2024 15:00 Corporate Governance Report 02/07/2024 15:00 Presentation on Business Results for the First Nine Months of FY 3/2024 02/07/2024 15:00 Consolidated Financial Statements for the First Nine Months of FY2024 02/07/2024 15:00 Notice concerning Change of Representative Directors and Organizational Changes and Personnel Changes 02/07/2024 15:00 Notice concerning Partial Change to Shareholder Benefit Program 02/07/2024 15:00 Notice concerning Revision of Consolidated Earnings Forecast and Dividend Forecast (Dividend Increase) for the Fiscal Year Ending March 31,2024 02/07/2024 15:00 Notice concerning Share Split, Amendents to the Articles of Incorporation, and Partial Change to the Matters related to Repurchase of the Company's Ow 02/07/2024 15:00 Notice concerning the Cancellation of Treasury Stock 01/18/2024 15:00 Notice concerning Transition to Company with Audit and Supervisory Committee and Establishment of Nomination and Remuneration Committee and Sustainabi 12/18/2023 16:35 Corporate Governance Report 11/07/2023 16:00 Consolidated Financial Statements for the First Six Months of FY2024 11/07/2023 16:00 Notice concerning the Cancellation of Treasury Stock 11/07/2023 16:00 Notice concerning Repurchase of Own Shares 11/07/2023 16:00 Presentation on Business Results for the First Half of FY 3/2024 09/22/2023 10:00 Notice concerning Results and Completion of Repurchase of the Company's Own Shares through Off-Auction Own Share Repurchase Trading (ToSTNeT-3) 09/21/2023 16:00 Notice concerning Repurchase of the Company's Own Shares and Acquisition of the Company's Own Shares through Off-Auction Own Share Repurchase Trading 09/21/2023 16:00 Notice of Change in Dividend Policy (Performance-linked Dividend) and Revision of Dividend Forecast (Dividend Increase) 09/21/2023 16:00 Notice concerning Earnings Forecast for the First Six Months of the Fiscal Year Ending March 31, 2024